270 related articles for article (PubMed ID: 29439956)
1. Species Identification and
Imbert S; Normand AC; Ranque S; Costa JM; Guitard J; Accoceberry I; Bonnal C; Fekkar A; Bourgeois N; Houzé S; Hennequin C; Piarroux R; Dannaoui E; Botterel F
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439956
[No Abstract] [Full Text] [Related]
2. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
[TBL] [Abstract][Full Text] [Related]
3. Azole-Resistance in
Zoran T; Sartori B; Sappl L; Aigner M; Sánchez-Reus F; Rezusta A; Chowdhary A; Taj-Aldeen SJ; Arendrup MC; Oliveri S; Kontoyiannis DP; Alastruey-Izquierdo A; Lagrou K; Cascio GL; Meis JF; Buzina W; Farina C; Drogari-Apiranthitou M; Grancini A; Tortorano AM; Willinger B; Hamprecht A; Johnson E; Klingspor L; Arsic-Arsenijevic V; Cornely OA; Meletiadis J; Prammer W; Tullio V; Vehreschild JJ; Trovato L; Lewis RE; Segal E; Rath PM; Hamal P; Rodriguez-Iglesias M; Roilides E; Arikan-Akdagli S; Chakrabarti A; Colombo AL; Fernández MS; Martin-Gomez MT; Badali H; Petrikkos G; Klimko N; Heimann SM; Uzun O; Roudbary M; de la Fuente S; Houbraken J; Risslegger B; Lass-Flörl C; Lackner M
Front Microbiol; 2018; 9():516. PubMed ID: 29643840
[No Abstract] [Full Text] [Related]
4. Aspergillus species collected from environmental air samples in Portugal-molecular identification, antifungal susceptibility and sequencing of cyp51A gene on A. fumigatus sensu stricto itraconazole resistant.
Monteiro C; Pinheiro D; Maia M; Faria MA; Lameiras C; Pinto E
J Appl Microbiol; 2019 Apr; 126(4):1140-1148. PubMed ID: 30735287
[TBL] [Abstract][Full Text] [Related]
5. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
[TBL] [Abstract][Full Text] [Related]
6. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.
Wang HC; Hsieh MI; Choi PC; Wu WL; Wu CJ;
Mycoses; 2023 Aug; 66(8):711-722. PubMed ID: 37186489
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources.
Tavakoli M; Rivero-Menendez O; Abastabar M; Hedayati MT; Sabino R; Siopi M; Zarrinfar H; Nouripour-Sisakht S; van der Lee H; Valadan R; Meletiadis J; Yazdani Charati J; Seyedmousavi S; Alastruey-Izquierdo A
Mycoses; 2020 Jan; 63(1):78-88. PubMed ID: 31609022
[TBL] [Abstract][Full Text] [Related]
9. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
Fernández MS; Rojas FD; Cattana ME; Sosa Mde L; Iovannitti CA; Lass-Flörl C; Giusiano GE
Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228
[TBL] [Abstract][Full Text] [Related]
11. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.
Kathuria S; Sharma C; Singh PK; Agarwal P; Agarwal K; Hagen F; Meis JF; Chowdhary A
PLoS One; 2015; 10(3):e0118997. PubMed ID: 25781896
[TBL] [Abstract][Full Text] [Related]
13. Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions.
Guinea J; Sandoval-Denis M; Escribano P; Peláez T; Guarro J; Bouza E
J Clin Microbiol; 2015 Feb; 53(2):611-7. PubMed ID: 25502530
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1998 Oct; 42(10):2726-30. PubMed ID: 9756785
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
[TBL] [Abstract][Full Text] [Related]
18. Antifungal Susceptibility of the Aspergillus viridinutans Complex: Comparison of Two
Lyskova P; Hubka V; Svobodova L; Barrs V; Dhand NK; Yaguchi T; Matsuzawa T; Horie Y; Kolarik M; Dobias R; Hamal P
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437620
[TBL] [Abstract][Full Text] [Related]
19. Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea.
Heo MS; Shin JH; Choi MJ; Park YJ; Lee HS; Koo SH; Lee WG; Kim SH; Shin MG; Suh SP; Ryang DW
Ann Lab Med; 2015 Nov; 35(6):602-10. PubMed ID: 26354348
[TBL] [Abstract][Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]